Vivos Therapeutics Inc (VVOS): Next-Year EPS Estimate 40.21%
As of 2026-06-04, Vivos Therapeutics Inc (VVOS) has a next-year EPS growth estimate of 40.21%.
On 2026-06-04, analyst consensus for VVOS's next-year EPS growth shifted from 85.89% to 40.21% — a negative change of 45.68 percentage points. Current-year growth is projected at 32.13%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 40.21%
- EPS growth this year
- 32.13%
- EPS next quarter (est)
- -$0.37
- Last price
- $0.69
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 40.21% | 32.13% | -$0.37 | $0.69 |
| 2026-06-03 | 85.89% | 40.10% | -$0.33 | $0.64 |
| 2026-06-02 | 85.89% | 40.10% | -$0.33 | $0.68 |
| 2026-06-01 | 85.89% | 40.10% | -$0.33 | $0.69 |
| 2026-05-31 | 85.89% | 40.10% | -$0.33 | $0.70 |
| 2026-05-28 | 85.89% | 40.10% | -$0.33 | $0.67 |
| 2026-05-27 | 85.89% | 40.10% | -$0.33 | $0.66 |
| 2026-05-26 | 69.65% | 44.28% | -$0.31 | $0.65 |
| 2026-05-25 | 69.65% | 44.28% | -$0.31 | $0.61 |
| 2026-05-24 | 69.65% | 44.28% | -$0.31 | $0.61 |
| 2026-05-21 | 69.65% | 44.28% | -$0.31 | $0.58 |
| 2026-05-20 | 69.65% | 44.28% | -$0.45 | $0.59 |
| 2026-05-19 | 69.65% | 44.28% | -$0.45 | $0.59 |
| 2026-05-18 | 69.65% | 44.28% | -$0.45 | $0.60 |
| 2026-05-17 | 69.65% | 44.28% | -$0.45 | $0.64 |
| 2026-05-14 | 69.65% | 44.28% | -$0.45 | $0.69 |
| 2026-05-13 | 69.65% | 44.28% | -$0.45 | $0.76 |
| 2026-05-12 | 69.65% | 44.28% | -$0.45 | $0.73 |
| 2026-05-11 | 69.65% | 44.28% | -$0.45 | $0.69 |
| 2026-05-10 | 69.65% | 44.28% | -$0.45 | $0.66 |
| 2026-05-07 | 69.65% | 44.28% | -$0.45 | $0.66 |
| 2026-05-06 | 69.65% | 44.28% | -$0.45 | $0.72 |
| 2026-05-05 | 69.65% | 44.28% | -$0.45 | $0.71 |
| 2026-05-04 | 69.65% | 44.28% | -$0.45 | $0.74 |
| 2026-05-03 | 69.65% | 44.28% | -$0.45 | $0.81 |
| 2026-04-30 | 69.65% | 44.28% | -$0.45 | $0.80 |
| 2026-04-29 | 69.65% | 44.28% | -$0.45 | $0.78 |
| 2026-04-28 | 69.65% | 44.28% | -$0.45 | $0.85 |
| 2026-04-27 | 69.65% | 44.28% | -$0.45 | $0.86 |
| 2026-04-26 | 69.65% | 44.28% | -$0.45 | $0.84 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Vivos Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Vivos Therapeutics Inc (VVOS) has a next-year EPS growth estimate of 40.21%, based on analyst consensus.
When was the latest EPS estimate revision for VVOS?▾
The most recent revision occurred on 2026-06-04, when analysts adjusted the next-year EPS growth estimate from 85.89% to 40.21%.
What sector and industry does Vivos Therapeutics Inc belong to?▾
Vivos Therapeutics Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. VVOS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Vivos Therapeutics Inc (VVOS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports